Slavic Magic has released a major new update for Manor Lords, its medieval strategy game, with the update adding a new option to choose starting ...

After a brutal drawdown, Vertex is quietly doing the things long-term investors usually say they want and one fund just ...

Vertex Pharmaceuticals (VRTX) just checked several big boxes at once, with upbeat pediatric data for CASGEVY, fresh momentum in its kidney disease program, and a wave of investor interest following ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has been ...

Vertex Pharma could be close to succeeding in the long-standing quest to find an alternative to potentially addictive opioids for the treatment of pain associated with common medical procedures.

Editorial Note: We earn a commission from partner links on Forbes Advisor. Commissions do not affect our editors' opinions or evaluations. Disclaimer: Calculator results and default inputs are ...

Investing.com -- Palo Alto Networks shares rose on Friday after the cybersecurity firm announced an expanded strategic ...

Investing.com -- Google has released Gemini 3 Flash, a new AI model designed to deliver high-level intelligence with faster processing speeds at lower costs.

Shares of Vertex Pharmaceuticals Inc. rose 6.92% to $463.13 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.30% to 6,849.72 ...